Exchange: NYSE·Updated 12:27 PM EDT
BHVN logo

BHVN Biohaven Pharmaceutical Holding Company Ltd

$15.57
$0.30
(1.97%)
Today
Reported EarningsAug 10
Mkt Cap$2.31B
Vol747,854.00

About BHVN

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
75

Extremely Bullish Sentiment

How do you feel about BHVN?

Advertisement|Remove ads.